Report updated May 13, 2026
GLP 1 Tracker - Within Reach
For individuals prescribed GLP-1 medications who require a private, automated tool to track medication adherence and health progress.
GLP 1 Tracker - Within Reach is a market-leading health & fitness app that is completely free. With a 4.8/5 rating from 12 reviews, it delivers strong user satisfaction. Users particularly value accountability features like daily check-in reminders help users maintain their health and exercise goals.
What is GLP 1 Tracker - Within Reach?
Within Reach is a privacy-focused health tracking app for GLP-1 medication users on iOS.
Users hire this app to manage the mental load of weekly medication adherence without exposing sensitive health data to third-party analytics firms.
Current Momentum
v1.3 · 2mo ago
Active- Improved bulk HealthKit sync performance.
- Maintains high user satisfaction ratings.
Active Nemesis
WeightWatchers Program
By WW International
Other Rivals
7-Day Rank Pulse 🇺🇸
Health & FitnessNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
Loading...
What Are The Key Features?
Health data is stored exclusively on the device and private iCloud, bypassing developer servers
Bi-directional data flow with Apple Health for weight and activity metrics
Voice-activated logging for medication and health tracking
How much does it cost?
- Fully free application with no mentioned IAP or subscription
The app operates as a free, privacy-focused utility with no current monetization gates observed.
Who Built It?
CoreBits
Providing specialized utility tools for personal finance, smart home automation, and health tracking. Focused on niche, task-specific mobile solutions for Apple users.
Portfolio
5
Apps
What other apps does CoreBits make?
Explore the full CoreBits report
Portfolio breakdown, audience, momentum, and every app published by CoreBits.
What do users think recently?
Low confidence · 4 reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a thrilled sentiment. Users appreciate accountability features like daily check-in reminders help users maintain their health and exercise goals and health data tracking capabilities provide users with a clear view of their personal progress.
Limited review volume (4 reviews). Sentiment analysis will deepen as more data lands.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for GLP 1 Tracker - Within Reach?
How's The Health & Fitness Market?
Market outlook for this category
Available very soon
Which niche is GLP 1 Tracker - Within Reach in?
to track medication and health progress
Explore the full Diabetes Management Trackers niche
Every app in this space — 46 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
NimbleRx dominates the medication management space by integrating prescription fulfillment directly into the user workflow, creating a high-friction barrier for users who want a one-stop shop for their GLP-1 journey.
Contenders(4)
This app competes as a general-purpose medication tracker that offers more granular inventory management than the target app.
This app targets the clinical outcome side of GLP-1 usage, competing for users who prioritize data-driven health monitoring over simple injection reminders.
WellView competes by providing pharmacy-centric tools that address the logistical hurdles of obtaining and paying for chronic medications.
This app competes by offering specialized dietary tracking and trigger management, which is a critical secondary need for GLP-1 users managing side effects.
Same space(3)
This app competes by bundling medication reminders with pharmacy-specific services like prescription ordering and family management.
Dose Medbox is a direct peer in the medication adherence space, focusing on high-frequency, simple interaction patterns.
Luka competes by offering a privacy-focused, widget-heavy UX that appeals to users who want quick, non-intrusive health data access.
Compare GLP 1 Tracker - Within Reach against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for GLP 1 Tracker - Within Reach
Strengths to defend, gaps to attack
Core Strengths
- Local-first storage architecture creates a privacy-based moat
- Siri integration lowers logging friction for daily users
- Apple Health bi-directional sync ensures data portability
Critical Frictions
- Zero-revenue model limits long-term sustainability
- Limited tracking metrics for comorbid conditions
- Small review volume restricts social proof
Growth Levers
- Develop premium modules for diabetes-specific tracking
- Integrate wearable data beyond Apple Health
- Introduce optional paid features for advanced analytics
Market Threats
- Incumbents can add GLP-1 tracking to paid programs
- AI-logging apps reduce the value of manual entry
- Lack of monetization limits marketing spend
What are the next best moves?
Ship diabetes-specific tracking modules because users request granular insulin data → increase retention in the chronic-condition segment
Top user request theme in sentiment analysis identifies a clear gap for users with insulin resistance.
Trade-off: Pause the development of new UI themes — specialized medical data is a higher-value retention lever.
Introduce a tiered subscription for advanced analytics because the current free model lacks revenue → fund future development
The app currently has no monetization, creating a sustainability risk against well-funded incumbents.
Trade-off: Deprioritize new feature development for one sprint to focus on billing infrastructure.
A counter-intuitive read
The app's lack of monetization is not a weakness but a deliberate strategy to build a high-trust user base that can be converted to a premium medical-grade utility once the user count reaches critical mass.
Feature Gaps vs Competitors
- Real-time behavioral coaching (available in Noom but absent here)
- Proprietary food database (available in WeightWatchers but absent here)
- AI-powered image recognition for food logging (available in Cal AI but absent here)
Key Takeaways
Within Reach succeeds as a privacy-focused utility for GLP-1 users, but its lack of monetization and narrow feature set leave it exposed to incumbents, so the PM should prioritize specialized medical tracking modules to secure a defensible market position.
Where Is It Heading?
Stable
The health tracking market is consolidating around apps that offer more than just logging, such as behavioral coaching and AI-driven insights. Within Reach is currently advantaged by its privacy stance, but it must evolve into a more specialized medical tool to avoid being commoditized by larger platforms that can bundle GLP-1 tracking for free.
High user satisfaction ratings indicate the core medication tracking loop effectively solves the user's primary pain point.
The absence of a monetization model limits the ability to scale marketing, leaving the app vulnerable to better-funded competitors.